title: The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.
authors.affiliation: Department of Oncology, Mater Salutis Hospital, Legnago, Italy. Electronic address: giuliani.jacopo@alice.it.
authors.forename: Jacopo
authors.initials: J
authors.lastname: Giuliani
authors.affiliation: Department of Oncology, Mater Salutis Hospital, Legnago, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Bonetti
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000188:drug therapy / Q000191:economics*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors
keywords: Advanced colorectal cancer; Advanced non–small-cell lung cancer; EGFR-inhibitors; Pharmacological costs; Skin toxicity